Professor Trent Munro


Professor Trent Munro is currently a Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland where he is Director of the National Biologics Facility and Program Director for the CEPI funded Vaccine Rapid Response pipeline. Prior to this he was Executive Director of Process Development at Amgen Inc., based in Thousand Oaks, California. Trent joined Amgen in 2013 and led analytical process development for the early stage clinical pipeline across all modalities. Before joining Amgen Dr Munro was an Associate Group Leader and Queensland Government Smart Futures Fellow at the AIBN. Dr Munro has a PhD in Protein Biochemistry from UQ and completed postdoctoral studies in cell biology and developmental genetics at the Department of Cell Biology, Harvard Medical School and at the Wellcome Trust and Cancer Research UK Gurdon Institute, University of Cambridge.